[Skip to content]

Search our Site
National Patient Safety Agency Patient Safety Division
National Patient Safety Agency - Patient Safety Division
.

Administering Vincristine

 

Issued: 1 Apr 2001

  • Vincristine is a chemotherapy drug, that is given intravenously. Since 1975, 14 people have died, including one this year, because it was mistakenly given intrathecally i.e. as a spinal injection.

  • Two recent reports, one by Professor Brian Toft and one by Professor Kent Wood make a number of recommendations to prevent another person dying as the result of the maladministration of vincristine and intrathecal chemotherapy.

  • The Chief Medical Officer, in a letter of 19 April 2001, asked all NHS trust chief executives to ensure that intrathecal chemotherapy is only administered by designated, trained staff. Is your Trust implementing this?

  • Further guidance laying down procedures that all NHS Trusts will be required to follow for the injection of chemotherapy will be issued soon.

  • The Department of Health is also investigating possible design solutions and the Committee on Safety In Medicines is looking at changes in packaging and labelling which could help prevent error

 

 

 

 

 

Patient Safety Division Announcements